[Helicobacter pylori infection and probiotics]

Nihon Saikingaku Zasshi. 2007 May;62(2):271-7. doi: 10.3412/jsb.62.271.

[Article in Japanese]

Author

Shigeru Kamiya¹

Affiliation

¹ Department of Infectious Diseases, Kyorin University School of Medicine.

PMID: 17575794
DOI: 10.3412/jsb.62.271

No abstract available

Publication types

Review

MeSH terms

2-Pyridinylmethylsulfinylbenzimidazoles / therapeutic use
Amoxicillin / therapeutic use
Animals
Bifidobacterium
Clarithromycin / therapeutic use
Clostridium butyricum
Drug Therapy, Combination
Helicobacter Infections / microbiology
Helicobacter Infections / prevention & control*
Helicobacter Infections / therapy*
Helicobacter pylori*
Humans
Lactobacillus
Lansoprazole
Probiotics* / adverse effects
Probiotics* / pharmacology
Probiotics* / therapeutic use
Saccharomyces

Substances

2-Pyridinylmethylsulfinylbenzimidazoles
Lansoprazole
Amoxicillin
Clarithromycin